EA004745B1 - Тетрагидробензазепиновые производные в качестве агонистов дофаминовых рецепторов d1 - Google Patents
Тетрагидробензазепиновые производные в качестве агонистов дофаминовых рецепторов d1 Download PDFInfo
- Publication number
- EA004745B1 EA004745B1 EA200100783A EA200100783A EA004745B1 EA 004745 B1 EA004745 B1 EA 004745B1 EA 200100783 A EA200100783 A EA 200100783A EA 200100783 A EA200100783 A EA 200100783A EA 004745 B1 EA004745 B1 EA 004745B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- mmol
- chloro
- hydrogen
- compound according
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903671.7A GB9903671D0 (en) | 1999-02-17 | 1999-02-17 | Dopamine D-1 receptor agonist compounds |
| PCT/GB2000/000570 WO2000049000A1 (en) | 1999-02-17 | 2000-02-17 | Dopamine d1 receptor agonist compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200100783A1 EA200100783A1 (ru) | 2002-02-28 |
| EA004745B1 true EA004745B1 (ru) | 2004-08-26 |
Family
ID=10847990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200100783A EA004745B1 (ru) | 1999-02-17 | 2000-02-17 | Тетрагидробензазепиновые производные в качестве агонистов дофаминовых рецепторов d1 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1157009A1 (es) |
| JP (1) | JP2002537288A (es) |
| KR (1) | KR20010108228A (es) |
| CN (1) | CN1142916C (es) |
| AU (1) | AU767332B2 (es) |
| BR (1) | BR0008329A (es) |
| CA (1) | CA2363695A1 (es) |
| CZ (1) | CZ20012973A3 (es) |
| EA (1) | EA004745B1 (es) |
| GB (1) | GB9903671D0 (es) |
| HU (1) | HUP0200057A3 (es) |
| IL (1) | IL144810A0 (es) |
| MX (1) | MXPA01008294A (es) |
| NO (1) | NO20013978L (es) |
| PL (1) | PL349838A1 (es) |
| WO (1) | WO2000049000A1 (es) |
| ZA (1) | ZA200106478B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| KR20080044840A (ko) | 2005-07-15 | 2008-05-21 | 에이엠알 테크놀로지, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기위한 용도 |
| AU2006278514A1 (en) * | 2005-08-03 | 2007-02-15 | Mia Levite | Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists |
| CN101684096A (zh) * | 2008-09-23 | 2010-03-31 | 中国科学院上海药物研究所 | 一类新型苯并氮杂卓类化合物及其制备方法和用途 |
| CN102276531A (zh) * | 2011-05-30 | 2011-12-14 | 扬子江药业集团广州海瑞药业有限公司 | 一种甲磺酸非诺多泮的制备方法 |
| CA2916653C (en) | 2013-06-27 | 2017-07-18 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561305A (en) * | 1975-07-02 | 1980-02-20 | Smithkline Corp | Benzazepine derivatives and pharmeceutical compositions containing them |
| US4111957A (en) * | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4265889A (en) * | 1978-05-05 | 1981-05-05 | Smithkline Corporation | 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| US4861771A (en) * | 1989-01-27 | 1989-08-29 | Smithkline Beckman Corporation | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs |
-
1999
- 1999-02-17 GB GBGB9903671.7A patent/GB9903671D0/en not_active Ceased
-
2000
- 2000-02-17 IL IL14481000A patent/IL144810A0/xx unknown
- 2000-02-17 KR KR1020017010418A patent/KR20010108228A/ko not_active Application Discontinuation
- 2000-02-17 MX MXPA01008294A patent/MXPA01008294A/es unknown
- 2000-02-17 CZ CZ20012973A patent/CZ20012973A3/cs unknown
- 2000-02-17 BR BR0008329-1A patent/BR0008329A/pt not_active IP Right Cessation
- 2000-02-17 CN CNB00803947XA patent/CN1142916C/zh not_active Expired - Fee Related
- 2000-02-17 HU HU0200057A patent/HUP0200057A3/hu unknown
- 2000-02-17 JP JP2000599740A patent/JP2002537288A/ja active Pending
- 2000-02-17 EP EP00903881A patent/EP1157009A1/en not_active Withdrawn
- 2000-02-17 CA CA002363695A patent/CA2363695A1/en not_active Abandoned
- 2000-02-17 EA EA200100783A patent/EA004745B1/ru not_active IP Right Cessation
- 2000-02-17 PL PL00349838A patent/PL349838A1/xx not_active Application Discontinuation
- 2000-02-17 AU AU25632/00A patent/AU767332B2/en not_active Ceased
- 2000-02-17 WO PCT/GB2000/000570 patent/WO2000049000A1/en not_active Application Discontinuation
-
2001
- 2001-08-07 ZA ZA200106478A patent/ZA200106478B/en unknown
- 2001-08-15 NO NO20013978A patent/NO20013978L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2563200A (en) | 2000-09-04 |
| WO2000049000A1 (en) | 2000-08-24 |
| ZA200106478B (en) | 2002-02-07 |
| HUP0200057A2 (en) | 2002-08-28 |
| NO20013978D0 (no) | 2001-08-15 |
| CN1341102A (zh) | 2002-03-20 |
| NO20013978L (no) | 2001-08-15 |
| BR0008329A (pt) | 2002-01-29 |
| MXPA01008294A (es) | 2002-07-02 |
| AU767332B2 (en) | 2003-11-06 |
| EP1157009A1 (en) | 2001-11-28 |
| KR20010108228A (ko) | 2001-12-07 |
| CN1142916C (zh) | 2004-03-24 |
| CZ20012973A3 (cs) | 2002-01-16 |
| GB9903671D0 (en) | 1999-04-14 |
| IL144810A0 (en) | 2002-06-30 |
| HUP0200057A3 (en) | 2004-03-29 |
| PL349838A1 (en) | 2002-09-23 |
| CA2363695A1 (en) | 2000-08-24 |
| EA200100783A1 (ru) | 2002-02-28 |
| JP2002537288A (ja) | 2002-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3299321B2 (ja) | ２−アミノメチル−クロマン類 | |
| KR100545329B1 (ko) | 인돌 및 2,3-디히드로인돌 유도체, 그들의 제조방법 및 사용 | |
| NZ512732A (en) | Piperidine, tetrahydropyridine and piperazine derivatives useful in treating affective disorders | |
| JP4861979B2 (ja) | テトラヒドロイソキノリンスルホンアミド誘導体、その調製及び治療における同誘導体の使用 | |
| NZ252098A (en) | 1-aryl-3-piperazino indane derivatives and medicaments | |
| CA2612109A1 (en) | Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists | |
| JPS6033409B2 (ja) | ベンズアゼピン誘導体を含む医薬組成物 | |
| KR100193981B1 (ko) | 신규한 8-치환-2-아미노테트랄린 | |
| EP0200455B1 (en) | 2,3,4,5-tetrahydro-1h-3-benzazepines substituted in position 5 | |
| SK93198A3 (en) | Quinoline-2-(1h)-one derivative, preparation method thereof and pharmaceutical composition containing the same | |
| EA004745B1 (ru) | Тетрагидробензазепиновые производные в качестве агонистов дофаминовых рецепторов d1 | |
| DE69418321T2 (de) | Tricyclische benzodiazepine, ihr verwendung und herstellung | |
| JP7390401B2 (ja) | 縮合環化合物、その製造方法及び用途 | |
| CA1079639A (en) | 3-benzazepine derivatives | |
| IE61006B1 (en) | New tricyclic amines derived from 2,3,5,6,7,8-hexahydronaphto (2,3-b) furan and from 2,3,6,7,8,9-hexahydro-5H-benzocyclohepta (2,3-b) furan, the processes for preparing them and the pharmaceutical compositions which contain them | |
| JP4608160B2 (ja) | 新規なフッ素化ベンゾジオキサンイミダゾリン誘導体、それらの製造方法およびそれらの治療用途 | |
| FI113770B (fi) | Menetelmä farmakologisesti aktiivisten 5-(2,3-dihydrobentsofuran-7-yyli)-7-hydroksi-3-metyyli-2,3,4,5-tetrahydro-1H-3-bentsatsepiinien valmistamiseksi | |
| US7026475B2 (en) | Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions | |
| KR100226328B1 (ko) | 4-(4-또는6-(트리플루오로메틸-2-피리디닐))-1-피페라지닐알킬치환된락탐 | |
| WO2001036428A1 (en) | Silylated heterocyclic compounds | |
| US6333329B2 (en) | 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |